This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Immunitybio, Inc., Nantbio, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Melanie Hermreck
Introduction
Melanie Hermreck is a prominent inventor based in Culver City, CA (US). She has made significant strides in the field of biotechnology, particularly in the development of novel therapeutic approaches for treating solid tumors. With a total of 2 patents to her name, her work is paving the way for advancements in cancer treatment.
Latest Patents
Hermreck's latest patents include groundbreaking innovations such as Anti-CTLA4 monoclonal antibodies and chimeric antigen receptors. Additionally, she has developed an intratumorally injected yeast vaccine, which comprises compositions and methods for treating solid tumors using yeast-based formulations. These patents reflect her commitment to improving cancer therapies and patient outcomes.
Career Highlights
Throughout her career, Melanie has worked with notable companies in the biotechnology sector, including ImmunityBio, Inc. and NantBio, Inc. Her experience in these organizations has allowed her to contribute to cutting-edge research and development in cancer immunotherapy.
Collaborations
Hermreck has collaborated with esteemed colleagues such as Thomas H. King and Zhimin Guo. These partnerships have further enhanced her research capabilities and have led to innovative solutions in the fight against cancer.
Conclusion
Melanie Hermreck's contributions to biotechnology and cancer treatment are noteworthy. Her patents and collaborations demonstrate her dedication to advancing medical science and improving patient care.